Upon completion of the activity, participants should be better able to: 1. Align management strategies with disease grade and current guidelines for hematopoietic stem cell transplantation (HSCT) recipients who develop acute graft-versus-host disease (aGvHD). 2. Assess the potential impact of recent data and ongoing clinical trials of emerging therapies on the management of aGvHD. 3. Integrate the unique roles and responsibilities of interprofessional care team members when managing HSCT-recipients with aGvHD.
- Provider:RMEI Medical Education, LLC
- Activity Link: https://rmei.com
- Start Date: 2024-12-31 06:00:00
- End Date: 2024-12-31 06:00:00
- Credit Details: IPCE Credits: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: CSL Behring, LLC - Amount: 67405.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology, Transplant Hepatology
Subscribe
Login
0 Comments
Oldest